Greg Foran and Brian Cornell mark their one-year anniversaries at Walmart U.S. and Target next month.» Read More
He's faced some tough choices, but Target CEO Brian Cornell is nailing it, says ex-Medtronic CEO Bill George.
Even without awards, a motion picture with memorable characters will win over the hearts - and wallets - of people everywhere.
Target CEO Brian Cornell said a deal announced this week with CVS will help his company focus on signature categories.
Discussing expansion efforts with TargetExpress stores, with Brian Cornell, Target Chairman & CEO.
Harvard Business School's Bill George, discusses Target's transformation, and its investment in CVS.
Brian Cornell, Target Chairman & CEO, explains the company's transformation strategy as it "gets back to its core DNA."
Brian Cornell, Target Chairman & CEO, provides insight to the company's wellness strategy.
Brian Cornell, Target Chairman & CEO, discusses the early stages company's transformation.
“Mad Money” host Jim Cramer issues a warning to Twitter—bye bye birdie?
"Fast Money" traders discussed how to play CVS' acquisition of Target's pharmacy business and Gap's restructuring plans.
Jim Cramer speaks with both CVS and Target CEOs on the pharmacy partnership announced. Could it provide healthy gains for your portfolio?
The "Fast Money" traders give their final trades of the day.
U.S. stocks closed lower as investors remained anxious over stalled Greece debt talks and the upcoming two-day Federal Reserve meeting.
CVS is buying Target's pharmacy business, but the deal shouldn't raise antitrust concerns or prices, NBC News reports.
June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's U.S. pharmacy and clinics businesses in a $1.9 billion deal that will help it bargain with drug makers for lower prices. "The addition of the Target pharmacy adds significant purchasing clout for pharmaceuticals," FBR Capital markets analyst Steven Halper wrote in a note.
CVS Health is buying the pharmacy and clinic businesses from Target. Those businesses will continue to operate as CVS stores within the larger Target stores.
Some of the names on the move ahead of the open.
June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's U.S. pharmacy and clinics businesses for about $1.9 billion to boost sales and prescription volumes. CVS's shares were up 0.4 percent at $102.65 in premarket trading on Monday, while Target's were flat at $79.50. Barclays is CVS's financial adviser, while Target's is Goldman Sachs.
CVS Health and Target on Monday announced a deal for CVS to acquire Target's pharmacy and clinic businesses for about $1.9 billion.
June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's pharmacy and clinic businesses for about $1.9 billion.